Quest Diagnostics <a href="https://www.reuters.com/markets/companies/DGX.N" target="_blank">(DGX.N)</a> on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein which can appear years befo…